drugset / Trial / NCT00928421
An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins
NaSingle-groupOpen-labelTreatment
Summary
To determine the effect and safety of Varisolve® 0.125% \[0.2%\]
Timeline
- Start
- 2009-06
- Primary completion
- 2009-12
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Polidocanol | Other / unclassified | 0.125 % | Intravenous |